Apixaban/warfarinHaemarthrosis and lack of efficacy: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1919卷 / 1期

关键词：

D O I：

10.1007/s40278-022-21042-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：100 / 100

相关论文

共 50 条

[1] Apixaban/warfarinMinor gastrointestinal bleeding and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1899 (1) : 61 - 61
[2] Apixaban/EdoxabanLack of efficacy : 2 case reports
Reactions Weekly, 2025, 2048 (1) : 52 - 52
[3] Andexanet alfa/apixaban/rivaroxabanBleeding and lack of efficacy: 9 case reports
Reactions Weekly, 2019, 1767 (1) : 41 - 41
[4] Apixaban/HeparinLack of efficacy : 2 case reports
Reactions Weekly, 2024, 2020 (1) : 72 - 72
[5] Apixaban/rivaroxabanLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1979 (1) : 61 - 61
[6] Apixaban/rivaroxabanGI bleeding, retroperitoneal bleeding and lack of efficacy: 4 case reports
Reactions Weekly, 2019, 1735 (1) : 44 - 44
[7] Apixaban/dabigatran-etexilate/rivaroxabanBleeding and lack of efficacy: 3 case reports
Reactions Weekly, 2024, 2028 (1) : 69 - 69
[8] Apixaban/rivaroxaban/warfarinVarious bleeding events and lack of efficacy: 21 case reports
Reactions Weekly, 2023, 1947 (1) : 80 - 80
[9] Apixaban/enoxaparin-sodium/heparinBleeding and lack of efficacy: 17 case reports
Reactions Weekly, 2022, 1928 (1) : 69 - 69
[10] Andexanet-alfa/apixaban/rivaroxabanVarious toxicities and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 43 - 43

← 1 2 3 4 5 →